{"schema_version":"secwatch.filing_event.v1","accession":"0000105770-22-000042","form_type":"8-K","ticker":"WST","cik":"0000105770","company_name":"WEST PHARMACEUTICAL SERVICES INC","filed_at":"2022-07-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.819311+00:00","generated_at":"2026-06-24T07:15:46.764152+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"West Pharma Q2 net sales $771M (+6.6%); cuts FY2022 guidance on FX and COVID decline","bullets":["Q2 net sales $771.3M (+6.6% reported, +13.1% organic); reported EPS $2.48, adjusted EPS $2.47.","Proprietary Products segment sales $653.7M (+11.3%, organic +18.3%) led by high-value components and devices.","Contract-Manufactured Products sales $117.8M (-13.6%, organic -8.9%) on lower diagnostic device component sales.","FY2022 guidance cut: net sales now $2.950-$2.975B (prior $3.050-$3.075B); adjusted EPS $9.00-$9.15 (prior $9.30-$9.45).","Guidance reflects $190M FX headwind and ~$85M decline in COVID-19 sales; base business growth partially offsets."],"urls":{"canonical":"https://secwatch.observer/filing/0000105770-22-000042","json":"https://secwatch.observer/filing/0000105770-22-000042.json","markdown":"https://secwatch.observer/filing/0000105770-22-000042.md","text":"https://secwatch.observer/filing/0000105770-22-000042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/105770/000010577022000042/0000105770-22-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105770/000010577022000042/wst-20220728.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T07:15:46.764152+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}